Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
HARRISBURG, Pa., April 13, 2026 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (NASDAQ: ORRF), the holding company of Orrstown Bank, announced today that it will report first quarter 2026...
-
Luxembourg, Switzerland, April 13, 2026 (GLOBE NEWSWIRE) -- Trasteel Holding S.A. (“Trasteel”), headquartered in Lugano (Switzerland) and Luxembourg, and Sizzle Acquisition Corp. II (Nasdaq: SZZL)...
-
Announcement of 1Q26 earnings release and earnings call dates.
-
NORTH PLAINS, Ore., April 13, 2026 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (the “Company”; Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today...
-
Milwaukee, WI, April 13, 2026 (GLOBE NEWSWIRE) -- WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to announce first quarter 2026 financial results after the close on Tuesday,...
-
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Ex-Broadcom Executive Brings Over 40 Years of Semiconductor Technology and Business Leadership Experience to Navitas’ Board as Part of Strategic Transformation to High-Power Markets TORRANCE,...
-
MIAMI, April 13, 2026 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the data and AI security leader, announced that it will report its first quarter 2026 financial results following the...
-
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patients with type 1 diabetes Initial efforts will...
-
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today...